Cargando…
新辅助免疫治疗联合化疗在可手术的非小细胞肺癌的初步疗效评估
BACKGROUND AND OBJECTIVE: Preliminary researches conformed that neoadjuvant immunotherapy combined with chemotherapy had a significant short-term effect in resectable non-small cell lung cancer (NSCLC), but there were few clinical trials about neoadjuvant chemoimmunotherapy in China. We aimed to ass...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246389/ https://www.ncbi.nlm.nih.gov/pubmed/34024062 http://dx.doi.org/10.3779/j.issn.1009-3419.2021.102.13 |
Ejemplares similares
-
可手术的局部晚期非小细胞肺癌的新希望:新辅助免疫治疗
Publicado: (2020) -
新辅助免疫治疗及联合化疗在NSCLC中的研究进展
Publicado: (2021) -
可切除非小细胞肺癌新辅助免疫治疗的进展
Publicado: (2020) -
辅助化疗在早期可手术非小细胞肺癌治疗中的地位
Publicado: (2011) -
Ⅲa期非小细胞肺癌新辅助化疗的疗效分析及应用价值
Publicado: (2017)